- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 8, 2024 | 17.38M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 13.01M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 3.75M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$4.64M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$10.35M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $13.1M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$33.1M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$33.51M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$20.66M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$10.61M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $36.72M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $38.93M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $36.72M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $38.93M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $3.55M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $5.4M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $3.61M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $5.42M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.20 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$3.58 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.20 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$3.58 |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $3.53M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $5.67M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$2.66M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$13.43M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$6.06M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$8.93M |
| Revenue | Q1 2024 · Mar 31, 2024 | $579K |
| Revenue | Q1 2024 · Mar 31, 2023 | $808K |
| Stock Repurchased | Q1 2024 · Mar 31, 2023 | $1.2M |